Daily as of 3 Nov 16:00 ET
- Price
- above both $32.00 vs 50 $26.93 / 200 $25.30
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 31 Jul 2026 · projected 27 bars out · tested 4 bars
ARQT | Arcutis BiotherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$32.00
+$0.74 (+2.37%)
Arcutis Biotherapeutics (ARQT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $32.07 vs 50 $25.82 / 200 $14.88
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 25 Aug 2025 · projected 22 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $32.00 vs 50 $28.82 / 200 $26.81
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 9 Oct 2026 bar 2 · projected 2 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Oct 2026 | 🟨Golden | 4-hour | 2 bars out | 1 bar cross test |
| 2 Oct 2026 | 💀Death | 4-hour | 1 bar out | 4 bar cross test |
| 29 Sep 2026 | 🟨Golden | 4-hour | 5 bars out | 1 bar cross test |
| 18 Sep 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 31 Jul 2026 | 🟨Golden steep | daily | 27 bars out | 4 bar cross test |
About ARQT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$53.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid